A randomised, open label, single dose, two periods, crossover study of the comparative pharmacokinetics of two alendronic acid formulations in healthy volunteers under fasted conditions: a pilot study.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-519666-43-00

Acronym

ALIQ-0124/PKP

Enrollment

Registered

2025-02-05

Start date

2025-03-04

Completion date

2025-03-26

Last updated

2025-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

not applicable (submitted trial is a pharmacokinetic study in healthy subjects)

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Czechia

None listed

Source: EU CTIS · Data processed: Feb 4, 2026